Generalized Tonic Clonic Seizure
3 clinical trials · Condition
◉ Watch Generalized Tonic Clonic Seizure
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. (NCT05064878) | Zogenix, Inc. | 2022-03-08 |
| Novel Helmet Design in Patients With Seizures (NCT03443388) | Michael A. Gelfand, MD, PhD | 2017-08-14 |
Track Generalized Tonic Clonic Seizure automatically
Every clearance here is in the API, with alerts when new ones post.